Share on StockTwits

Cynapsus Therapeutic (NASDAQ:CYNAF) issued its quarterly earnings data on Thursday. The company reported ($0.04) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.03) by $0.01, AnalystRatingsNetwork.com reports.

Shares of Cynapsus Therapeutic (NASDAQ:CYNAF) opened at 0.535 on Thursday. Cynapsus Therapeutic has a one year low of $0.33 and a one year high of $1.39. The stock has a 50-day moving average of $0.59 and a 200-day moving average of $0.7. The company’s market cap is $42.1 million.

On a related note, analysts at Zacks reiterated an “outperform” rating on shares of Cynapsus Therapeutic in a research note on Wednesday. They now have a $2.25 price target on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.